Qi, Jieyu
Zhang, Liyan
Lu, Ling
Tan, Fangzhi
Cheng, Cheng
Lu, Yicheng
Dong, Wenxiu
Zhou, Yinyi
Fu, Xiaolong
Jiang, Lulu
Tan, Chang
Zhang, Shanzhong
Sun, Sijie
Song, Huaien
Duan, Maoli https://orcid.org/0000-0002-8437-1583
Zha, Dingjun https://orcid.org/0000-0002-9380-9209
Sun, Yu https://orcid.org/0000-0002-1771-3715
Gao, Xia https://orcid.org/0000-0002-4539-5929
Xu, Lei https://orcid.org/0000-0002-8509-6042
Zeng, Fan-Gang https://orcid.org/0000-0002-4325-2780
Chai, Renjie https://orcid.org/0000-0002-3885-543X
Article History
Received: 3 October 2024
Accepted: 15 May 2025
First Online: 2 July 2025
Competing interests
: W.D., S.Z. and C.T. were paid employees of Otovia Therapeutics Inc. L.J. is a paid employee of Otovia Therapeutics Inc. S.S. and H.S. are paid employees of Otovia Therapeutics Inc. and Fosun Health Capital. R.C. is the unpaid chief scientist of Otovia Therapeutics Inc. The other authors declare no competing interests.